American Conference Institute will be holding its 12th annual "Maximizing Pharmaceutical Patent Lifecycles" conference in New York City on October 4-5, 2011.  I will have the pleasure of speaking at this conference once again–this time on method-of-use patents and inducement of infringement.  The discounted early-registration rate expires Friday, August 12th, so move quickly!

The conference agenda includes:

  • Understanding How the Patent Cliff Will Redefine the Endgame
  • USPTO Keynote: The Impending Reality of Patent Reform and its Potential Impact on Pharmaceutical Patents
  • Life Cycle Management Controversies Posed by the Biosimilars Act
  • Patent Term Adjustment and Patent Term Extensions Update: Strategies and Considerations for Small and Large Molecules
  • Exploring Post-Issuance PTO Procedures in the Era of the Patent Cliff: Focus on Reexam and Reissue Proceedings
  • The Combined Impact of Prior Art Obviousness and Obvious-Type Double Patenting on Pharmaceutical Patent Life Cycle Strategies
  • Personalized Medicine and Patent Life Cycle Considerations Vis-a-Vis Sections 101, 112, and Allowable Research Exceptions
  • CAFC and Supreme Court Watch: Three Cases That May Have a Radical Impact on Pharmaceutical Patent Life Cycle Strategies
  • FTC Keynote: Analysis of Competitive Behaviors in Pharmaceutical Patent Life-Cycle Management Strategies
  • REMS Studies and Generic Entry: Exploring the Latest Regulatory Conundrum Affecting Pharmaceutical Patent Life Cycle Strategies
  • Carve-Outs, Skinny Labeling and Use Codes: Understanding Their Role in Orange Book Listing Strategies and Life Cycle Management
  • Inducement Actions and Divided Infringement: How Method-of-Use Claims Controversies are Influencing Orange Book Listings (I'll be speaking on this panel)
  • Exclusivities and Forfeitures: New Developments, Controversies and Concerns
  • FDA Keynote: Update on FDA Activities Impacting Pharmaceutical Patent Life Cycles for Small and Large Molecules
  • Safe Harbor or Stormy Port?  Calming the Legal Tempest Left by Proveris

In addition to the main conference, ACI will offer two pre-conference workshops on October 3rd:  "PTA-PTE Boot Camp: Basic Training in the Essentials of Patent Term Adjustment and Patent Term Restoration for Patent Lawyers Serving the Biopharmaceutical Industry"; and "Working Group on Global Pharmaceutical Patent Life Cycle Management Strategies for Established and Emerging Markets: A Practical, Hands-On Guide to Patent Extensions and Exclusivities Available to Pharmaceutical Products Around the World".

Orange Book Blog is a media partner of this conference, so readers are eligible for a $200 discount (beyond any other discounts) by using registration code OBB 200.  For more information or to register, please visit the conference website.

Posted in

Leave a comment